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Background: Several cohort studies have indicated associations between S. pneumoniae and other microbes in the
nasopharynx. To study causal relationships between the nasopharyngeal microbiome and pneumococcal carriage,
we employed an experimental human pneumococcal carriage model. Healthy adult volunteers were assessed for
pneumococcal carriage by culture of nasal wash samples (NWS). Those without natural pneumococcal carriage
received an intranasal pneumococcal inoculation with serotype 6B or 23F. The composition of the nasopharyngeal
microbiome was longitudinally studied by 16S rDNA pyrosequencing on NWS collected before and after challenge.
Results: Among 40 selected volunteers, 10 were natural carriers and 30 were experimentally challenged. At
baseline, five distinct nasopharyngeal microbiome profiles were identified. The phylogenetic distance between
microbiomes of natural pneumococcal carriers was particularly large compared to non-carriers. A more diverse
microbiome prior to inoculation was associated with the establishment of pneumococcal carriage. Perturbation of
microbiome diversity upon pneumococcal challenge was strain specific. Shifts in microbiome profile occurred after
pneumococcal exposure, and those volunteers who acquired carriage more often diverted from their original profile.
S. pneumoniae was little prominent in the microbiome of pneumococcal carriers.
Conclusion: Pneumococcal acquisition in healthy adults is more likely to occur in a diverse microbiome and appears
to promote microbial heterogeneity.
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Streptococcus pneumoniae (the pneumococcus) is one of
the organisms that commensally reside in the human
nasopharynx. Recently, an experimental human pneumo-
coccal carriage model was established [1] which enables
the controlled study of pneumococcal carriage episodes in
the human nasopharyngeal niche. An episode of pneumo-
coccal carriage is usually a beneficial immunogenic event
[2], but it is also the potential initiation of invasive
pneumococcal infections [3]. Pneumococcal carriage is
most prevalent in children under 5, ranging from 10% up* Correspondence: aldert.zomer@radboudumc.nl
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unless otherwise stated.to 90% depending on specific age group and setting [4,5],
and is generally less prevalent in adults [6-12]. The inci-
dence of invasive pneumococcal disease (IPD) is 10–20/
100,000/year in developed countries [13-16] and is esti-
mated to be even higher in developing countries [17], with
those under 5 and over 50 years old most at risk. Annu-
ally, pneumonia causes an estimated 1.3 million childhood
deaths worldwide [18]. The burden of IPD may be re-
duced by limiting the degree of pneumococcal carriage.
Insight into the determinants of pneumococcal carriage
will provide better understanding of how interference with
this phenomenon could influence its prevalence. Known
determinants of pneumococcal carriage are host traits re-
lated to exposure and immunity [4,19,20], antibiotic use,
and pneumococcal vaccination [12]. An additional elem-
ent that appears to be associated with pneumococcal car-
riage in children is the endogenous microbiota present inl. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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reported that in children, nasopharyngeal carriage of
S. pneumoniae is inversely correlated with carriage of
S. aureus [21-24]. Furthermore, investigation of the
pediatric nasopharyngeal niche by a 16S rDNA sequencing
approach has revealed associations between pneumococcal
carriage and specific bacterial genera [25]. However, as
these studies are cross-sectional, it is unknown how the en-
dogenous nasopharyngeal microbiota modulates the estab-
lishment of pneumococcal carriage and what changes are
brought about upon exposure to pneumococci. In this
study, we compared the composition of the nasopharyn-
geal microbiome with and without naturally acquired
pneumococcal carriage in healthy adults. In addition, a
unique experimental human pneumococcal carriage model
was employed to study whether specific compositions of
the microbiota are associated with subsequent establish-
ment of pneumococcal carriage and whether the adult
nasopharyngeal microbiome is perturbed by exposure
to S. pneumoniae.
Results
Selected volunteers and quality of samples
Among the 40 volunteers selected for microbiome analysis,
10 were natural carriers. The remaining 30 non-carriers
were experimentally challenged. Pneumococcal carriage as
detected by culture was established in 14 of the 26 selected
volunteers who were inoculated with serotype 6B, and
in 2 of the 4 challenged with serotype 23F. From these
40 volunteers, 117 samples were eligible for microbiome
data analysis (Additional file 1: Table S1). The composi-
tions of the individual 117 adult nasopharyngeal micro-
biomes are displayed in Additional file 2: Figure S1. The
measured read count, richness, and diversity per sample
were not influenced by the 16S rDNA concentration in
the extracted DNA samples (Additional file 3: Figure S2).
Distinct metagenomic profiles exist in the adult
nasopharyngeal microbiome
The genera most frequently detected in the adult naso-
pharyngeal microbiome at baseline were Corynebacter-
ium, Dolosigranulum, Staphylococcus, and Streptococcus
(Additional file 4: Table S2). Starting from these most
abundant genera, using hierarchical clustering and prin-
cipal component analysis (PCA) on microbial densities
of 155 operational taxonomic units (OTUs) present in
the individual adult nasopharyngeal communities, five dis-
tinct microbiome profiles were identified and appointed
as profile A to E (Figure 1). Corresponding PCA plots and
principal coordinate analysis (PCoA) plots are displayed in
Additional file 5: Figure S3. The random forest analysis
showed a low (~15%) overall out of bag error between the
class assignments of the samples, supporting the cluster-
ing analysis. In addition, the Pearson distances withinprofiles were lower compared with the distance between
samples from different profiles (median (IQR): 0.25 (0.07–
0.45) and 0.79 (0.51–0.95), respectively, p <0.0001). The
most important taxa that allowed differentiation between
the profiles were Corynebacterium spp., Streptococcus spp.,
Staphylococcus spp., Dolosigranulum, Peptoniphilus, and
Prevotella as illustrated in Additional file 6: Figure S4.
Among the five profiles, no differences in microbiome
richness (number of different OTUs, p =0.92) or diversity
(Shannon index, p =0.20; phylogenetic distance (PD) whole
tree, p =0.53) were observed. Whereas the microbiomes of
volunteers in profile B to E were all characterized by one
or two specified OTUs, within profile A, the PDs between
microbiomes were larger (unweighted UniFrac p =0.7,
weighted UniFrac p <0.0001). Profile A was more fre-
quently associated with natural pneumococcal carriage
compared with the other profiles (p =0.0045) (Figure 2).
When comparing volunteers with and without natural
pneumococcal carriage, no differences in microbiome rich-
ness (p =0.24) or diversity (Shannon index, p =0.36; PD
whole tree, p =0.44) were observed. The PDs between
the microbiomes of the natural pneumococcal carriers
were larger compared with those in non-carriers (both
unweighted and weighted UniFrac p <0.0001; Figure 3).
The nasopharyngeal microbiome as a determinant of
experimental pneumococcal carriage
The five microbiome profiles observed at baseline were
not associated with successful pneumococcal carriage after
inoculation with serotype 6B (Additional file 7: Figure S5),
unlike the association observed for natural pneumococcal
carriage. We did observe a positive association between a
more diverse microbiome prior to challenge with serotype
6B or 23F (Shannon index 6B or 23F p =0.034; serotype
6B alone p =0.076) and successful experimental pneumo-
coccal carriage (Figure 4). The relative abundance of spe-
cific OTUs as a determinant of pneumococcal carriage
upon challenge with serotype 6B is displayed in Additional
file 8: Figure S6. The p values of differences at OTU level
were not significant after correction for multiple testing.
Changes in microbiome profile are associated with
successful pneumococcal carriage
Carriage of S. pneumoniae was not associated with a spe-
cific concurrent microbiome profile in the first 2 weeks
after challenge (Additional file 9: Figure S7). The fraction
of volunteers shifting to a different microbiome profile
was stable over time (44%, 46%, and 48%, respectively,
p =1), so the time from challenge did not affect the
number of shifts. Volunteers who acquired pneumo-
coccal carriage less often returned to their original
microbiome profile at 14 days post challenge (5/13
versus 12/14, p =0.018). None of the pneumococcal
carriers had turned to the Staphylococcus-dominant
Figure 1 Characteristics of the adult nasopharyngeal microbiome at baseline. Each volunteer is represented by a branch of the circular
hierarchical clustering tree. From inside out, at baseline, five distinct adult nasopharyngeal microbiome profiles were identified from the individual
nasopharyngeal bacterial communities, appointed A to E (I). The individual microbiome compositions are proportionally displayed at genus level
(II). Natural pneumococcal carriers are marked in green, experimentally colonized volunteers in red, and those without pneumococcal acquisition are
depicted in grey (III). The length of the blue bars displays the diversity of the microbiome at baseline (IV). This figure was generated using iTOL [26].
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profile C was involved in profile shifts, as divergence from
and convergence to profile C did not differ from rates in
other profiles (44% versus 45%, p =1, and 38% versus 47%,
p =0.6, respectively).
Perturbations in microbiome diversity appear to be strain
dependent
Intranasal inoculation with a serotype 6B strain was not
associated with consistent perturbations in the nasopha-
ryngeal microbiome with respect to richness, diversity,
and PD from the composition prior to challenge. In contrast,inoculation with a serotype 23F strain was associated with a
transient increase in diversity in all volunteers (Shannon
index: increase from day −7 to 2, p =0.004; decrease from
day 2 to 7, p =0.083; Figure 5). The observed transient
increase in richness was not significant (increase from
day −7 to 2, p =0.25; decrease from day 2 to 7, p =0.13),
indicating that not only an increase in the number of dif-
ferent OTUs occurred after challenge but also equalization
of the relative abundance of different OTUs. The PD to the
microbiome prior to inoculation with serotype 23F in-
creased from day 2 to day 7 in all volunteers but was
not statistically significant (weighted UniFrac p =0.13).
Figure 2 Distribution of natural pneumococcal carriers over
baseline microbiome profiles. **: p <0.01.
Cremers et al. Microbiome 2014, 2:44 Page 4 of 10
http://www.microbiomejournal.com/content/2/1/44Differences in relative abundance of specific OTUs after
pneumococcal challenge with serotype 6B are displayed in
Additional file 10: Figure S8. The p values of differences at
OTU level were not significant after correction for mul-
tiple testing.
Discussion
We longitudinally studied the composition of the naso-
pharyngeal microbiome in healthy adults before and
after experimental pneumococcal challenge. At baseline,
five nasopharyngeal microbiome profiles were identified
with different natural pneumococcal carriage rates. The
PD between microbiomes of natural carriers was par-
ticularly large compared with that of non-carriers. A
more diverse microbiome prior to challenge was associ-
ated with subsequent establishment of pneumococcal
carriage. Those volunteers who acquired carriage more
often diverted from their original microbiome profile
than non-carriers. Furthermore, perturbation of micro-
biome diversity upon exposure to pneumococci appeared
to be strain dependent.
The unique experimental human pneumococcal carriage
model mimics natural colonization and allows discrimin-
ation between microbial determinants and consequences
of pneumococcal carriage. Rapid processing of samples en-
sured a high DNA yield for accurate microbiome data.
Pneumococcal carriage was assessed by culture—the gold
standard—which has been demonstrated to be a robust
method in nasal wash samples [27]. Based on 97% read
identity after pyrosequencing of the V3-V6 region of the
16S rDNA gene, it was not possible to differentiate be-
tween S. pneumoniae and other streptococci relevant
to the nasopharyngeal niche (i.e., S. mitis, S. mutans,
and S. pseudopneumoniae). Although it may be pos-
sible to confirm pneumococcal carriage by sequencing
the V1-3 region [28], V3-V6 was selected as it ensures
high coverage and high phylogenetic resolution for a
universal approach in a niche of interest.
The relatively small number of volunteers impeded
studying the involvement of specific OTUs in pneumococ-
cal carriage. Volunteers inoculated with different dosescould be grouped, because the applied doses conferred
similar rates and densities of pneumococcal carriage [2].
The unequal group sizes per inoculation strain were due
to a difference in colonization efficiency between the two
strains applied (Gritzfeld and coworkers, submitted for
publication). Another limitation was the inability to con-
trol other environmental influences like natural exposure
and viral infection. Inherent to the model, those volun-
teers most at risk for acquiring pneumococcal carriage
may actually have been the natural carriers who were not
inoculated.
In this study, clustering of individual microbial commu-
nities into microbiome profiles was performed without
weighting of phylogenetical distances between OTUs, be-
cause phylogenetically closely related OTUs may still
show distinct patterns in the human nasopharyngeal
niche. Compared with four highly robust microbiome pro-
files, profile A contained more heterogeneous micro-
biomes and may therefore hold subprofiles not identified
by this study. Although a similar grouping of bacteria was
observed in sampling from the anterior nares in the
Human Microbiome Project [29], already within the
nasal cavity, three distinct epithelium type-specific micro-
biota have been identified [30]. Therefore, it seems in-
appropriate to directly compare the identified microbiome
profiles in the nasopharynx—habitat to the pneumococ-
cus—to those in other nasal sites. Consistent with a study
that specifically investigated the nasopharyngeal niche in
healthy Chinese undergraduates [31], the top four most
abundant bacterial phyla present in the adult nasopharyn-
geal microbiome at baseline were Actinobacteria, Fimi-
cutes, Proteobacteria, and Bacteroidetes. The same holds
true for the top three most abundant genera observed:
Corynebacterium, Dolosigranulum, and Staphylococcus.
Streptococcus ranked fourth in our study, but it was
not mentioned in the top nine reported by the Chinese
study. This may be explained by differences in our
study population (i.e., more volunteers, slight overrepre-
sentation of natural carriers, and distinct geographical re-
gion) or the use of different nasopharyngeal sampling
methods.
The adult nasopharyngeal microbiome differed from that
in children. At phylum level, we observed an increased
abundance of Actinobacteria (3% in children, >30% in
adults) and a decreased abundance of Proteobacteria (64%
in children, <15% in adults) [31,32]. Whereas pneumococ-
cal carriage in children has previously been associated with
a high level of Streptococci in the nasopharynx and a low
diverse concurrent microbiome [25,33], in our adult volun-
teers, natural pneumococcal carriage was associated with
low proportions of streptococcal reads next to normally
diverse and phylogenetically heterogeneous microbiome
compositions. This may indicate that, in contrast to chil-
dren, in adults, the pneumococcus generally does not
Figure 4 Microbiome diversity prior to inoculation in
volunteers with and without establishment of pneumococcal
carriage. Microbiome richness (A) diversity (Shannon index) (B) and
PD whole tree, (C). *: p <0.05.
Figure 3 Within-group phylogenetic distance of baseline
microbiomes in volunteers with or without natural
pneumococcal carriage. Unweighted UniFrac (A) and weighted
UniFrac (B). ****: p <0.0001.
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upon acquisition.
We observed that a more diverse microbiome prior to
challenge was associated with the establishment of pneumo-
coccal carriage when combining the data from both
23F- and 6B-inoculated volunteers. We have noted
that there may be strain-specific effects on the micro-
biome composition following successful colonization,
and therefore, we cannot exclude strain-specific micro-
biome diversity requirements for successful colonization.However, the decrease in p value while combining the
23F and 6B data suggests that this is not the case, mak-
ing pooling a valid approach. Although in other host-
associated microbial communities a more diverse
microbiota was found to be associated with resistance
to pathogens, we did not observe this phenomenon in
our study. Here, a more diverse nasopharyngeal micro-
biome appears to facilitate pneumococcal carriage. As
Figure 5 Perturbations in the nasopharyngeal microbiome after pneumococcal challenge. Microbiome richness (A) and diversity (B) and
its phylogenetic divergence from the microbiome prior to challenge (C). 6B inoculated with serotype 6B, 23F inoculated with serotype 23F; *:
p <0.05.
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event [2], we speculate that short-term low-level pneumo-
coccal carriage actually promotes health as this will boost
protective immunity against the pneumococcus.
None of the volunteers with the Staphylococcus-dominated
microbiome profile C acquired pneumococcal carriage, and
none of the pneumococcal carriers turned to profile C. This
observation is in line with the frequently described inverse
correlation between carriage of S. pneumoniae and S. aureusin both children and adults [11,21-24], although we cannot
exclude that a different Staphylococcus species is responsible
for the observed phenomenon in our case. After pneumo-
coccal challenge, we observed continuous shifts in micro-
biome profiles, although volunteers without pneumococcal
acquisition more often returned to their original pro-
file. Stability in the upper respiratory tract microbiome
has been noted before by Charlson et al., where the naso-
pharyngeal community composition was less robust over
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remained relatively stable [34]. Furthermore, whereas
challenge with serotype 6B was not associated with spe-
cific changes in microbiome diversity, challenge with sero-
type 23F was. As the 23F-inoculated volunteers were
primarily staphylococcal carriers, this may have influenced
the changes observed. However, the increased variability
after challenge with 23F was not observed in other volun-
teers with Staphylococcus-dominated profiles who were
challenged with 6B. Therefore, we suggest that perturba-
tions in microbiome diversity after pneumococcal expos-
ure may be strain dependent.
Conclusions
In healthy adults, the nasopharyngeal microbiome can
be subdivided in at least five bacterial community classes
having at least four distinct profiles, with profiles B–E
dominated by Streptococcus spp., Staphylococcus spp.,
Corynebacterium spp., or a combination of Corynebac-
terium spp. and Dolosigranulum, whereas profile A is
more diverse. There is evidence of an inverse correlation
between carriage of S. pneumoniae and S. aureus. In our
study, a more diverse microbiome was associated with
the establishment of pneumococcal carriage. Further-
more, S. pneumoniae was generally little prominent in
carriers and its acquisition appears to promote microbial
heterogeneity. Whether pneumococcal carriage in healthy
adults is a prosperous event besides one related to disease
remains to be elucidated.
Methods
Experimental study model
We performed the experimental human pneumococcal
carriage model as previously described [1]. In short,
healthy adult volunteers were recruited in the United
Kingdom according to inclusion and exclusion criteria
described [1]. At baseline, we collected a nasal wash
sample (NWS) and assessed pneumococcal carriage by
culture of the NWS specimen. Of the 40 volunteers in-
cluded for microbiome analysis, 10 were natural carriers.
Those volunteers who were not natural pneumococcal
carriers were inoculated with either a serotype 6B strain
(BHN418 [35]) or 23F strain (P833 [36]) at 60,000- to
320,000-colony-forming-unit (CFU) S. pneumoniae as
these generally have a low invasiveness rate and have
been successfully used in previous carriage studies
[1,35]. Follow-up NWS were collected at 2, 7, and
14 days after challenge. Acquisition of pneumococcal
carriage with the inoculated strain was determined by
culture and confirmed by latex agglutination serotyping
of recovered strain. This study has been conducted ac-
cording to the Declaration of Helsinki principles, and
ethical approval was obtained from the National Health
Service Research Ethics Committee, Sefton, Liverpool(11/NW/0592). Written informed consent was received
from all volunteers prior to inclusion in the study.
Bacterial DNA extraction
Directly after NWS collection, we mixed 2 ml of the
sample with 4 ml RNAprotect Bacteria Reagent (cat. no.
76506, Qiagen, Venlo, The Netherlands) to precipitate
and protect nucleic acids in the sample. After 5 min of
incubation at room temperature (RT), the sample was
stored at −80°C until further use. The thawed 6-ml sus-
pension was pelleted in a 2-ml tube by three centrifuga-
tion steps, each for 20 min at 13,200 rpm at 4°C in a
microcentrifuge (cat. no. 5415R, Eppendorf, Hamburg,
Germany). To the pellet, we added 0.3 ml lysis buffer
with protease (Agowa Mag mini DNA extraction kit, cat.
no. NAP40401, LGC Genomics, Berlin, Germany), 50 mg
sterilized zirconia/silica beads (diameter 0.1 mm, cat. no.
11079101z, BioSpec Products, Bartlesville, OK, USA), and
0.3 ml phenol (Phenol BioUltra, cat. no. 77607, Sigma-
Aldrich, St. Louis, MO, USA). The sample was mechanic-
ally disrupted by bead beating in a TissueLyser LT (cat.
no. 85600, Qiagen, Venlo, The Netherlands) for two times
2 min at 50 Hz, cooling the sample on ice after each step.
We centrifuged the homogenate for 10 min at 10,000 rpm
at RT and transferred the aqueous phase to a 1.5-ml tube.
After addition of a binding buffer (twice the aqueous
phase volume) and 10 μl of magnetic beads, the sample
was incubated for 30 min at RT in a mixing machine. We
washed the magnetic beads with 200 μl of each wash buf-
fer 1 and 2 and eluted the DNA with 63 μl elution buffer
according to the manufacturer’s instructions.
Bacterial DNA quantification and sample selection
We determined the bacterial DNA concentration in each
eluate by qPCR on the 16S rDNA gene. The primer and
probe sequences were as follows: forward primer 5′-CGA
AAG CGT GGG GAG CAA A-3′; reverse primer 5′-GTT
CGT ACT CCC CAG GCG G-3′; probe 5′-(FAM)-ATT
AGA TAC CCT GGT AGT CCA-(MGB)-3′ as previously
published by Bogaert et al. [32]. The 25-μl PCR mix was
1× TaqMan Universal PCR Master Mix, 10 μM of each pri-
mer (1 μl), 5 μM probe (1 μl), 6.5 μl DNA-free water, and
3 μl template DNA. Thermal cycling was performed in a
ABI 7500 Fast Real-Time PCR System (cat. no. 4351107,
Life Technologies, Carlsbad, CA, USA), with the following
cycling conditions: 2 min 50°C, 10 min 95°C, and 50 cycles
of 15 s at 95°C and 1 min at 65°C. The 16S rDNA standard
curve consisted of a 10-fold dilution series of a mix of gen-
omic DNA extracted from three bacteria common to
the respiratory tract: Streptococcus pneumoniae (TIGR4),
Moraxella catarrhalis (RH4), and Haemophilus influenzae
(1521062). We extracted genomic DNA with the Qiagen
Genomic-tip 20/G Kit (cat. no. 10223, Qiagen, Venlo, The
Netherlands) and quantified it by a spectrophotometer
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DE, USA). Those volunteers whose extracted DNA sam-
ples all contained at least 1 pg bacterial DNA/μl [37] were
considered eligible for microbiome analysis. To avoid
false-positive results, both DNA extraction and amplifica-
tion procedures were accompanied by negative controls.
16S rDNA pyrosequencing and handling of DNA
sequences
We amplified the V3-V6 region of the 16S rDNA gene
with forward primer 5′-CCA TCT CAT CCC TGC GTG
TCT CCG ACT CAG NNNNNN ACT CCT ACG GGA
GGC AGC AG-3′ (italicized sequence: 454 Life Sciences
primer A; bold sequence: broadly conserved bacterial
primer 338 F; NNNNNN: the sample-specific six-base
barcode used to tag each PCR product) and reverse pri-
mer 5′-CCT ATC CCC TGT GTG CCT TGG CAG TCT
CAG CRR CAC GAG CTG ACG AC-3′ (italicized se-
quence: 454 Life Sciences primer B; bold sequence:
broadly conserved bacterial primer 1061R). We purified
the amplicons from the PCR product using two kits con-
secutively according to their manufacturer’s instructions:
the MSB Spin PCRapace Kit (cat. no. 1020220400, Isogen,
De Meern, The Netherlands) and the PureLink Quick
PCR Purification Kit (cat. no. K310002, Life Technologies,
Bleiswijk, The Netherlands) using binding buffer 3B and
an elution volume of 40 μl. A composite sample for pyro-
sequencing was prepared by pooling 100 ng purified PCR
product from each sample. Fifty microliters of the ampli-
con library (concentration 14.5 ng/μl) was submitted
for pyrosequencing on the 454 Life Sciences GS-FLX +
platform using Titanium sequencing chemistry (both
Roche, Germany) at GATC Biotech, Konstanz, Germany.
One hundred seventeen samples were analyzed (Additional
file 1: Table S1).
We analyzed the pyrosequencing data with a workflow
based on QIIME v1.2 [38], using settings as recom-
mended in the QIIME 1.2 tutorial, with the following ex-
ceptions: reads were filtered for chimeric sequences
using ChimeraSlayer [39], and OTU clustering was per-
formed with settings as recommended in the QIIME
newsletter 2010 [40]. The RDP classifier version 2.2 was
performed for taxonomic classification [41]. Samples with
read counts below 500 were excluded from further
analysis. Sequence data and subject characteristics are
available at http://www.cmbi.ru.nl/bamics/supplementary/
cremers_2014_ehpc/index.htm.
Diversity estimates, correlation, and clustering analysis
To correct for differences in read count while calculating
diversity estimates, individual sample data were down-
sampled to the lowest read count included in the study.
We measured alpha diversity within samples by richness
(number of OTUs) and two diversity estimates: theShannon index that increases with OTU number and
with equality of OTU abundances, and the PD whole
tree which accentuates phylogenetically distant OTUs.
We measured beta diversity between samples by the
UniFrac distance that estimates the fraction of a sample’s
phylogenetic tree that differs from another sample, with
(weighted) or without (unweighted) emphasis on the
most abundant OTUs. Starting from the most abundant
genera present in the nasopharynx at baseline, we stud-
ied the presence of microbiome profiles using hierarch-
ical clustering by Pearson correlations and PCA on
microbial density expressed as the percentage of reads in
a sample that is assigned to a specific OTU, where an
OTU should account for at least 1% of the reads in one
sample. PCA on OTU abundance data and PCoA on
weighted and unweighted UniFrac distances were per-
formed in R using prcomp and labDSV [42], respectively,
with default settings. Random forest analysis with micro-
biome profiles as classes and the microbial density data as
classifiers was performed using the randomForest package
in Bioconductor [43]. In addition, we compared Pearson
distances within profiles to those between profiles. The
microbial communities observed in samples collected
after inoculation were allocated to a microbiome profile
using random forest analysis handling microbial density
data as described above. Correlation analysis between
OTUs was performed by pairwise Spearman’s correlations.
Statistical analyses
Differences in dichotomous variables (pneumococcal
carriage) were statistically tested by a Fisher’s exact
test. Normality of the distribution of continuous vari-
ables was tested by Shapiro-Wilk test. Differences in
microbiome characteristics by normally distributed
variables (Shannon index, PD whole tree) were statisti-
cally tested by an unpaired t-test for two independent
groups or a one-way analysis of variance (ANOVA) for
multiple independent groups and by a paired t-test or
repeated-measures one-way ANOVA for perturbations in
the microbiome over time. Differences in not normally
distributed variables (number of OTUs, Pearson distance,
UniFrac) were statistically tested by a Mann-Whitney U
test for two independent groups or a Kruskal-Wallis test
for multiple independent groups. To test perturbations in
the microbiome over time, a Wilcoxon matched-pairs
signed rank test or Friedman test was applied. For all ana-
lyses, the significance level was set at 0.05. Multiple testing
correction was performed by the Benjamini-Hochberg
false discovery rate procedure [44].
Availability of supporting data
Sequence data and subject characteristics are avail-
able at http://www.cmbi.ru.nl/bamics/supplementary/
cremers_2014_ehpc/index.htm.
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Additional file 1: Table S1. Samples selected for microbiome analysis
and their bacterial DNA concentrations by 16S rDNA qPCR (pg/μl).
Additional file 2: Figure S1. Microbiome composition of the 117
individual nasopharyngeal samples represented at genus level. Positive
pneumococcal culture results are displayed on the left (green: natural
carrier, red: carriage of inoculation strain) and their individual diversity
metrics on the right.
Additional file 3: Figure S2. Correlation between 16S rDNA quantity
and read count, richness, and diversity. The 16S rDNA concentration in
the extracted DNA samples has not influenced the sequencing yield in
terms of the number of reads (p =0.074) (panel A), the number of OTUs
(p =0.64) (panel B), or the Shannon index (p =0.14) (panel C) per sample.
Additional file 4: Table S2. Most prevalent bacterial genera present in
the adult nasopharynx at baseline by natural carriage status.
Additional file 5: Figure S3. PCA and PCoA plots of the individual
nasopharyngeal microbial communities at baseline. PCA principal
component analysis, PCoA principal coordinate analysis. Individual
volunteers are displayed as dots colored according to microbiome
profile, in two-dimensional graphs with combinations of the three PCA
components on the axes (panel A). PCoA was performed on unweighted
and weighted UniFrac distances (panel B).
Additional file 6: Figure S4. The percentage of reads from each OTU
that differentiates between the microbiome profiles per NWS. NWS nasal
wash sample.
Additional file 7: Figure S5. Distribution of experimental
pneumococcal carriers over the five nasopharyngeal microbiome profiles
at baseline. Volunteers who received a pneumococcal challenge with
serotype 6B are displayed.
Additional file 8: Figure S6. OTU abundances at baseline in volunteers
with or without acquisition of experimental pneumococcal carriage.
Volunteers who received a pneumococcal challenge with serotype 6B are
displayed. Nodes represent taxa, and edges link the different taxonomic
levels. The fold increase is calculated as the log2 of the ratio of the
relative abundance in pre-existing microbiome compositions of volunteers
without and with establishment of pneumococcal carriage after challenge
(0 = no difference between those who did and did not establish carriage,
1 = twice as abundant in those who established carriage, and so on).
The significance is expressed as the p value of a Mann-Whitney U test
of the baseline samples from all challenged volunteers. Note that the
relation between node size and total abundance is non-linear.
Additional file 9: Figure S7. Distribution of pneumococcal culture-
positive samples after challenge with serotype 6B over the microbiome
profiles.
Additional file 10: Figure S8. Changes from baseline OTU abundances
2 days after pneumococcal challenge among serotype 6B-challenged
volunteers. Nodes represent taxa, and edges link the different taxonomic
levels. The fold increase is calculated as the log2 of the ratio of the relative
abundance in samples before and 2 days after pneumococcal challenge
(0 = no difference between before and after challenge, 1 = twice as
abundant after challenge, and so on). The significance is expressed as the
p value of a Mann-Whitney U test of the samples before and 2 days after
challenge. Note that the relation between node size and total abundance
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